Actively Recruiting

Age: 20Years - 60Years
All Genders
Healthy Volunteers
NCT06298682

Characterization of Exosomes Platelets-released

Led by Centro Cardiologico Monzino · Updated on 2024-03-12

175

Participants Needed

1

Research Sites

312 weeks

Total Duration

On this page

Sponsors

C

Centro Cardiologico Monzino

Lead Sponsor

F

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Collaborating Sponsor

AI-Summary

What this Trial Is About

Extracellular vesicles (EVs) play a key role in cell-to-cell communication. They are small vesicles that contain rich molecular cargo. Recently, they have been proposed as biomarkers for clinical diagnostics. EVs include three classes: small EVs (exosomes), large EVs (microparticles), and apoptotic bodies. Platelet-derived EVs (PEVs) are the most abundant class in human blood and can actively participate in numerous physiological and pathological processes. The information about the role of platelet exosomes in cardiovascular disease and the effect of antiplatelet agents on their release and content is very limited.

CONDITIONS

Official Title

Characterization of Exosomes Platelets-released

Who Can Participate

Age: 20Years - 60Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Subjects without known pathologies
Not Eligible

You will not qualify if you...

  • Individuals with gastrointestinal diseases
  • Individuals with history of hepatic diseases
  • Individuals with history of urogenital diseases
  • Individuals with history of hematological diseases
  • Individuals with history of immunological diseases
  • Individuals with history of renal diseases
  • Individuals with history of metabolic diseases
  • Individuals with history of respiratory diseases
  • Individuals with history of cancer
  • Individuals with history of cardiovascular disease
  • Individuals having permanent organ damage
  • Individuals with major trauma in the last 6 months prior to enrollment
  • Individuals with surgery in the last 6 months prior to enrollment
  • Individuals taking medication in the 15 days prior to enrolment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Milan, Italy

Actively Recruiting

Loading map...

Research Team

S

Silvia S Barbieri, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here